Wednesday, March 10, 2010

Portfolio News

CellCentric Licenses Novel Epigenetic Discovery Programme to Takeda

Published: 2010-02-23 12:46:13

CellCentric epigenetic imprint erasure factor published in Nature

Published: 2010-01-26 16:58:26

Update on divestment of business assets

Published: 2010-01-21 17:01:29

Intercytex Group plc

Published: 2009-12-07 09:17:10

Crescendo Biologics Raises £4.5 million in Seed-Funding

Published: 2009-10-12 10:34:43

Mike Romanos Appointed as CSO of Crescendo Biologics

Published: 2009-10-12 10:31:54

PAION Announces Patient Recruitment for Phase IIa Study

Published: 2009-09-08 10:10:49

Intercytex: Suspension of trading on AIM

Published: 2009-09-02 10:22:47

Intercytex Group plc: Update on strategic review

Published: 2009-07-01 13:59:40

York Pharma plc - Directorate Change

Published: 2009-06-26 09:00:55

York Pharma plc - Update on merger discussions

Published: 2009-06-24 09:13:11

CellCentric: From Imprinting to the Epigenome in 25 years

Published: 2009-06-02 11:49:29

Intercytex Update at AGM

Published: 2009-05-20 11:43:29

CellCentric Widens Drug Screening in Shanghai

Published: 2009-05-06 14:50:58

Intercytex Group welcomes announcement of Pfizer - UCL collaboration

Published: 2009-04-24 13:58:37

CellCentric Secures 25th Epigenetics Academic Agreement

Published: 2009-04-21 10:12:58

PAION initiates Phase II trial with its anesthetic/sedative CNS 7056

Published: 2009-04-15 08:37:10

PAION and Ergomed report full data of phase IIa study in neuropathic pain

Published: 2009-04-09 15:08:29

Amura reports antigen presentation study results

Published: 2009-04-07 16:03:02

Amura announces positive results in chronic neuropathic pain model

Published: 2009-04-07 15:55:05

Amura announces further positive results in a human breast cancer model

Published: 2009-04-07 15:40:23

Amura reports osteoarthritis study exceeded expected endpoints

Published: 2009-04-07 15:25:39

Intercytex plc: Preliminary results for the year ended 31 December 2008

Published: 2009-03-26 09:55:48

Intercytex: Clarification regarding Strategic Review

Published: 2009-02-23 12:44:36

Intercytex: Phase III results of Cyzact fail to meet primary endpoint

Published: 2009-02-23 11:03:45

Intercytex implements restructuring actions to reduce cash burn

Published: 2009-01-26 08:17:13

York Pharma plc Board Changes & Market Update

Published: 2009-01-20 15:58:10

York Pharma - Update on Solvay Acquisition

Published: 2009-01-14 09:44:11

CellCentric Collaborates on Epigenetic Programme with Takeda

Published: 2009-01-06 09:16:24

York Pharma announces sales collaboration with Sinclair Pharma

Published: 2008-12-22 09:33:33

Intercytex Group plc – Acquisition of stem cell company Axordia Limited

Published: 2008-12-22 09:29:35

York Pharma plc - Acquisition and Placing

Published: 2008-10-28 08:29:48

York Pharma: Completion of EUR28.5 million acquisition
Completion of EUR28.5 million acquisition of leading dermatological & wound care brands
Published: 2008-10-01 13:20:26

Intercytex: Institutional placing raises £2.75 million

Published: 2008-09-09 09:01:57

ImmBio-Led Consortium Releases Promising Data for Meningitis B Vaccine

Published: 2008-09-05 13:55:22

Intercytex appoints new Chief Financial Officer

Published: 2008-08-26 08:44:09

York Pharma plc: Acquisition and financing
Acquisition of leading dermatological and wound care brands, $48 million (£24.2 million) fianncing and £3.9 million institutional placing.
Published: 2008-07-07 08:11:27

Intercytex completes recruitment for Phase III trial of ICX-PRO

Published: 2008-06-05 08:22:31

Intercytex plc: funding award from US Government
AFIRM will use regenerative medicine to develop new treatments for battlefield injuries
Published: 2008-04-18 08:04:03

Recommended Acquisition of CENES PHARMACEUTICALS PLC by PAION AG

Published: 2008-04-10 08:48:37

CeNeS Pharmaceuticals plc proposed acquisition by PAION AG

Published: 2008-04-10 08:34:36

York Pharma: date of interim results and trading update

Published: 2008-04-09 08:25:33

Intercytex: Preliminary results for the year ended 31 December 2007

Published: 2008-03-18 07:41:10

CeNeS Pharmaceuticals plc - Potential Offer

Published: 2008-02-05 14:14:28

Intercytex - Year-end clinical trial update

Published: 2007-12-18 08:10:36

Aitua Ltd Portfolio Company Establishes Worldwide Distributor Network
Lightning-Link™ company Innova completes agreement with Japanese distributor
Published: 2007-12-13 11:24:54

CeNeS - Update on M6G

Published: 2007-12-06 08:41:17

York Pharma Preliminary Results for the Year Ended 30 Sep 2007

Published: 2007-11-23 08:32:12

CellCentric and Cancer Research Technology Collaboration

Published: 2007-11-14 09:43:58

York Pharma plc Research Update
New Abasol(TM) formulation for onychomycosis can effectively and rapidly penetrate the nail barrier
Published: 2007-10-30 11:31:55

York Pharma plc £17.5m Acquisition of Derms Development

Published: 2007-10-09 08:39:14

CellCentric receives funding from Takeda Research Investment, Inc.
Existing shareholders including Morningside and NESTA contribute to Series A fund alongside the endorsement from a corporate pharmaceutical investor.
Published: 2007-10-02 08:40:46

Recommended Cash Offer for COZART PLC by CONCATENO PLC

Published: 2007-10-01 12:58:17

Intercytex Group plc Interim results for the six months ended 30 June 07

Published: 2007-09-25 10:52:47

CeNeS Interim Results for the six months ended 30 June 2007

Published: 2007-09-13 13:59:16

CeNeS: Start of Recruitment for Phase II trial of CNS 5161 in cancer pain

Published: 2007-09-10 11:45:04

Cozart plc - Recommended Cash Offer by Concateno plc

Published: 2007-09-05 08:02:44

Cozart plc - Preliminary Results
Cozart plc increases revenue by 52% and trebles operating profit
Published: 2007-09-05 07:43:57

Cozart plc - Rule 2.4 announcement

Published: 2007-09-04 09:26:51

CeNeS Pharmaceuticals plc - AGM and EGM

Published: 2007-08-22 10:46:38

CeNeS Licenses New Intravenous Anaesthetic to Ono in Japan

Published: 2007-08-06 10:28:56

Cozart plc - Home Office Expands Drugs Intervention Programme

Published: 2007-07-30 07:42:36

CeNeS: Proposed placing to raise £6.1m and consolidation of share capital

Published: 2007-07-27 11:06:06

Intercytex announces introduction of Vavelta at FACE

Published: 2007-07-02 07:50:14

Cozart Signs Commercialisation Agreement with Philips Electronics
Cozart to market Cozart-Philips drug testing product worldwide Philips increases equity stake in Cozart to 9%
Published: 2007-06-28 07:48:03

Intercytex announcement - world first in skin repair

Published: 2007-06-26 08:55:51

CeNeS Pharmaceuticals plc Pipeline Update – CNS 7056

Published: 2007-06-20 08:44:54

CellCentric signs IP agreement with Massachusetts General Hospital

Published: 2007-06-15 12:12:15

CeNeS announces further statistical analysis of recent Phase III trial
Further statistical analysis of the recent Phase III trial on Lead Product M6G shows additional benefits
Published: 2007-06-08 08:21:28

Cozart appointed into 4-year Framework Agreement with UK Home Office

Published: 2007-06-06 08:12:08

Cozart plc awarded contract with Emirates Airlines

Published: 2007-05-09 08:03:16

Intercytex Group plc - Proposed Placing

Published: 2007-05-03 08:06:51

Cozart: Scottish Executive awards contract for Oral Fluid Drug testing

Published: 2007-04-10 09:16:12

De Novo Announces New Partnering Opportunity in Diabetes

Published: 2007-04-09 12:13:17

York Pharma plc Pre-close Trading Update
Strong progress on product pipeline
Published: 2007-03-28 13:39:45

CeNeS: Preliminary results for the year ended 31 December 2006
Product profile of lead drug candidate (M6G) confirmed in large Phase III study International partnering process to commercialise M6G underway
Published: 2007-03-28 12:04:17

CeNeS Appoints Rodman & Renshaw to assist in partnering of M6G

Published: 2007-03-28 12:02:45

CeNeS: IND For Lead Product M6G Filed

Published: 2007-03-28 12:01:09

Intercytex Preliminary results for the year ended 31 December 2006

Published: 2007-03-23 14:34:21

Acquisition of DanioLabs
Associated Link - Acquisition strengthens Avlar BioVentures in VC market - press release 2 October 2006
Published: 2007-03-22 14:42:48

Takeda to Acquire Paradigm Therapeutics

Published: 2007-03-12 09:55:54

MDY Healthcare plc participates in fundraising of Cozart plc
Fundraising to finance acquisition of Nemesis Scientific Limited
Published: 2007-03-02 10:25:30

Cozart plc Acquisition of Nemesis Scientific Limited
Expansion of presence in the workplace drug testing market
Published: 2007-03-02 10:22:02

Amura Holdings Ltd assignment of rights to ProtoDiscovery™ platform

Published: 2007-02-21 15:49:32

CeNeS: Successful Phase III results announced on Lead Product M6G
Phase III trial in Europe demonstrates M6G's benefit compared to morphine in the treatment of post-operative pain.
Published: 2007-02-20 08:04:29

CeNeS announces update on its portfolio of carried interests

Published: 2007-02-20 07:58:29

Intercytex: Skin graft substitute (ICX-SKN) commences Phase I

Published: 2007-02-19 13:07:49

Cozart doubles turnover compared to H1 2005/6
Considerable progress made on joint development, with Philips Electronics, of biosensor saliva drugs of abuse system
Published: 2007-01-25 14:28:42

CellCentric expands its epigenetic discovery network

Published: 2007-01-24 11:57:30

CeNeS Pharmaceuticals plc: Placing to raise £4.82m

Published: 2006-12-04 10:16:07

Amura - orally active cathepsin K inhibitors with anti-osteoclast activity

Published: 2006-11-23 09:57:09

CeNeS Pharmaceuticals plc Positive Clinical Study Published on M6G

Published: 2006-10-19 09:28:49

Intercytex awarded £1.85m grant from the DTI
Intercytex awarded £1.85m grant from the DTI to automate production of innovative hair regeneration therapy
Published: 2006-10-06 08:20:15

Babraham BioConcepts announces key appointments

Published: 2006-10-06 08:03:34

Acquisition strengthens Avlar BioVentures in VC market

Published: 2006-10-02 15:07:49

CeNeS plc Interim Results for the six months

Published: 2006-09-28 09:39:50

CeNeS plc Update on Lead Product M6G

Published: 2006-09-28 09:33:00

Intercytex Group plc - Interim results for six months ended 30 June 06
Intercytex Group plc (LSE: ICX) announces its interim results for the six months ended 30 June 2006.
Published: 2006-09-21 11:11:37

Cozart plc Directors Share Purchase

Published: 2006-09-20 11:36:22


News Archive
2004 News Archive